Droplite Technologies careers
DROPLITE is a biotechnology company introducing a novel in-vitro smart diagnostics device, that in solely 10 min delivers accurate test results on the detection and quantification of specific diseases and health conditions, based on an immunoassay biochemical testing technique. Our primary goal is to bring an on-site testing solution to doctors and patients that is - faster, automated and easier-to-use than the established, slow and complex laboratory tests. Our patent-pending optical sensing technology combined with nanotechnology and dedicated immunoassay chemistry, is designed for versatility, reliability and automation. Our main market is the in-vitro fertility sector, where our novel solution quantifies sexual hormones in blood in a matter of minutes, in particular estradiol, a critical hormone tested in every fertility treatment cycle. In addition to fertility, we are exploring in parallel an additional beachhead market: veterinary - in the rapid detection of pet diseases. The inclusion of this market is purely strategic, since it allows us to start commercialization earlier, given its lower legislation and certification barrier. DROPLITE has achieved central-lab quality results, reducing by 10-fold the test times and sample volume, using our reader-cartridge prototype. Our goal is to provide a test solution to diagnose and start the treatment in same medical appointment, without the need of a laboratory, long waiting times and second visits to the clinic/hospital. This concept applies to the fertility sector, veterinary and other human markets we are exploring, in particular allergies and infectious diseases.
Droplite Technologies hasn't added any jobs yet
Get notified when Droplite Technologies posts new jobs.
André Guedes
Founder and CEO at @Droplite Technologies, SL. PhD in Physics. Co-founded in San Francisco de startups @PicoSense and @Chirp.io (Chirp) Microsystems (acquired in 2018 by TDK). 10+ patents.
Valuation
$0
Funded over
1 round
Latest round
Pre-Seed (May 2020)
Amgen • Thousand Oaks • $171k – $232k • 1 week ago
Pacific Biosciences • Menlo Park • $148k – $222k • 1 week ago
Glaxosmithkline • Seattle • $158k – $264k • 1 week ago
Noble Biomaterials • Scranton • $64k – $84k • 1 week ago
Penumbra • Roseville • $126k – $180k • 3 weeks ago
